Brendan Bulik-Sullivan
InvestorGeneral Partner at GV (Google Ventures)
San Francisco, California
Writes $250K – $50M checks · typically $25M
Find your path to Brendan
Sign up to see every warm intro you have to Brendan
- Paths you didn't know you had: your email and LinkedIn already hold routes to Brendan. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
General partner at GV focused on life sciences investments, interested in therapeutic biotechnology and diagnostics across all stages. Before GV, he worked on applied statistics and machine learning in genetics and biotech at Gritstone Oncology and the Broad Institute, with published research in Nature and Science. He holds a B.A. in mathematics from UC Berkeley and a Ph.D. in statistical genetics from Vrije Universiteit Amsterdam.
Invests in
AI & Machine LearningBiotech
Beyond investing
- Education
- Studied at University of California, Berkeley (B.A., Mathematics) Studied at Vrije Universiteit Amsterdam (PhD, Statistical Genetics)
- More
- Bulik-Sullivan developed the LD Score Regression method for statistical genetics, resulting in publications in Nature and Science.
From published sources — common ground for a warm intro.
Investments
Board seats
Investor
Areteia TherapeuticsBitterroot BioComanche BiopharmaEncoded TherapeuticsMaze TherapeuticsMetseraSanta Ana BioSonoma BiotherapeuticsTaysha Gene TherapiesVentus TherapeuticsVicinitas Therapeutics
Per curated public sources.
Colleagues at GV (Google Ventures)
Network11
Investors connected to Brendan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Brendan Bulik-Sullivan?
- General partner at GV focused on life sciences investments, interested in therapeutic biotechnology and diagnostics across all stages. Before GV, he worked on applied statistics and machine learning in genetics and biotech at Gritstone Oncology and the Broad Institute, with published research in Nature and Science. He holds a B.A. in mathematics from UC Berkeley and a Ph.D. in statistical genetics from Vrije Universiteit Amsterdam.
- Where does Brendan Bulik-Sullivan work?
- Brendan Bulik-Sullivan is General Partner at GV (Google Ventures).
- What does Brendan Bulik-Sullivan invest in?
- Brendan Bulik-Sullivan invests in AI & Machine Learning, Biotech.
- What check size does Brendan Bulik-Sullivan write?
- Brendan Bulik-Sullivan typically writes checks of $250K – $50M.
- What boards does Brendan Bulik-Sullivan sit on?
- Brendan Bulik-Sullivan holds tracked board seats at Santa Ana Bio, Ventus Therapeutics.
- What companies has Brendan Bulik-Sullivan invested in?
- Investments tracked here include Comanche Biopharma, Areteia Therapeutics, Bitterroot Bio, Comanche Biopharma, Encoded Therapeutics, Maze Therapeutics, Metsera, Santa Ana Bio, Sonoma Biotherapeutics, Taysha Gene Therapies, Ventus Therapeutics, Vicinitas Therapeutics.
- Does Brendan Bulik-Sullivan lead rounds?
- Yes — Brendan Bulik-Sullivan has led 1 tracked investment.
About this profile. Compiled from public sources — GV (Google Ventures)'s own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights












